Non-alcoholic Fatty Liver Disease
Information
- Disease name
- Non-alcoholic Fatty Liver Disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05637866 | Active, not recruiting | SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes | October 1, 2022 | October 1, 2023 | |
| NCT05209100 | Active, not recruiting | Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease | February 11, 2022 | December 2024 | |
| NCT05035043 | Active, not recruiting | N/A | Economic Burden of NAFLD | March 1, 2021 | April 30, 2024 |
| NCT03912272 | Active, not recruiting | N/A | 12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat | January 1, 2019 | January 1, 2024 |
| NCT06348628 | Active, not recruiting | N/A | Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease | May 31, 2022 | July 2025 |
| NCT03674528 | Active, not recruiting | Technical Validation of MR Biomarkers of Obesity-Associated NAFLD | May 4, 2018 | September 2024 | |
| NCT04227782 | Active, not recruiting | MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH) | March 1, 2020 | October 1, 2027 | |
| NCT02579408 | Active, not recruiting | Quantifying Steatosis in Liver Transplant Donors | October 2015 | May 2026 | |
| NCT02500147 | Active, not recruiting | Phase 4 | Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) | September 8, 2011 | November 30, 2025 |
| NCT02506946 | Active, not recruiting | NAFLD in Adolescents and Young Adults With PCOS | July 2013 | December 2022 | |
| NCT01856465 | Active, not recruiting | Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery | June 2013 | August 30, 2023 | |
| NCT03375788 | Active, not recruiting | Phase 2 | Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk | January 17, 2019 | December 1, 2024 |
| NCT01104220 | Active, not recruiting | N/A | Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk | April 2010 | December 2024 |
| NCT03179657 | Active, not recruiting | Guangzhou Nutrition and Health Study (GNHS) | July 1, 2008 | December 2027 | |
| NCT03260036 | Active, not recruiting | Hepatic Urea Nitrogen Handling in Patients With NASH | August 21, 2017 | August 21, 2025 | |
| NCT00887393 | Completed | N/A | Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates | April 2009 | December 2012 |
| NCT00889577 | Completed | Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons | December 2008 | December 2013 | |
| NCT01007955 | Completed | Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery | November 2006 | May 2012 | |
| NCT01056133 | Completed | Phase 2 | Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH) | October 2009 | August 2015 |
| NCT01094158 | Completed | Phase 2 | Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis | November 2010 | January 2012 |
| NCT06024681 | Completed | N/A | Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis | July 20, 2021 | October 31, 2023 |
| NCT01257685 | Completed | Selenoprotein P and Non-alcoholic Fatty Liver Disease | September 2007 | August 2008 | |
| NCT01262326 | Completed | N/A | Determination of the Effect of Extreme Dietary Carbohydrate Restriction on Hepatic Glucose Production | January 2005 | December 31, 2011 |
| NCT01285362 | Completed | N/A | Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study | March 2013 | September 2014 |
| NCT01317576 | Completed | N/A | Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver! | March 2011 | November 2015 |
| NCT01371396 | Completed | N/A | Effect of Dietary Macronutrient Composition | September 1, 2007 | December 31, 2013 |
| NCT01373554 | Completed | Phase 2 | Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease | May 2011 | October 2013 |
| NCT01431521 | Completed | Phase 1 | Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008) | October 26, 2011 | October 1, 2012 |
| NCT05946148 | Completed | Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18) | June 1, 2018 | May 31, 2021 | |
| NCT01547910 | Completed | Phase 2 | Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in Children | August 2007 | April 2012 |
| NCT01548079 | Completed | N/A | Ursodeoxycholic Acid in Bariatric Surgery | October 2008 | May 2010 |
| NCT01579162 | Completed | N/A | Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation | January 2012 | April 2015 |
| NCT05897606 | Completed | Phase 1 | Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD | February 1, 2023 | May 3, 2023 |
| NCT05885373 | Completed | N/A | A Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLD | March 1, 2023 | December 31, 2023 |
| NCT01654549 | Completed | Phase 2 | Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis | April 2012 | September 2012 |
| NCT05813249 | Completed | Phase 4 | Semaglutide in Nonalcoholic Fatty Liver Disease | February 15, 2023 | April 1, 2024 |
| NCT01680640 | Completed | N/A | Investigation of Synbiotic Treatment in NAFLD | December 2013 | January 2019 |
| NCT01696487 | Completed | N/A | Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study. | February 2012 | February 2014 |
| NCT01712711 | Completed | Phase 2 | Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease | September 2012 | March 2013 |
| NCT01747772 | Completed | N/A | Sonoelastography: Ultrasound Method to Measure Liver Fibrosis | February 2010 | February 14, 2014 |
| NCT01759628 | Completed | Phase 2 | Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease | April 2012 | June 2013 |
| NCT05810506 | Completed | Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements | October 1, 2021 | March 17, 2023 | |
| NCT05808049 | Completed | N/A | A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver Health | October 6, 2022 | July 4, 2023 |
| NCT01875978 | Completed | N/A | Effect of Phytosterols on Nonalcoholic Fatty Liver Disease | October 2012 | July 2013 |
| NCT01958411 | Completed | Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG) | December 2008 | ||
| NCT01963845 | Completed | Phase 2 | Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease | January 2014 | January 2016 |
| NCT01975935 | Completed | Phase 2 | Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients | January 2014 | August 18, 2017 |
| NCT01985009 | Completed | N/A | Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference. | January 2014 | January 17, 2017 |
| NCT05807204 | Completed | N/A | Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal Obesity | May 1, 2023 | January 11, 2024 |
| NCT02006498 | Completed | Phase 2 | Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) | June 2012 | December 2015 |
| NCT05804422 | Completed | N/A | Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study) | February 1, 2023 | December 31, 2023 |
| NCT05742919 | Completed | Phase 1 | A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men | February 16, 2023 | June 13, 2023 |
| NCT02077374 | Completed | Phase 2 | A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases | March 2014 | March 2015 |
| NCT02116192 | Completed | N/A | Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents | April 2014 | October 2017 |
| NCT02132780 | Completed | Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease | May 2014 | May 2016 | |
| NCT02147925 | Completed | Phase 4 | Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects | August 2014 | April 2017 |
| NCT05611567 | Completed | N/A | Endoscopic Gastric Plication Using the POSE2.0 Technique for Management of Fatty Liver Disease | January 20, 2020 | September 1, 2022 |
| NCT02176811 | Completed | Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease | June 2009 | February 2014 | |
| NCT02242149 | Completed | Phase 3 | Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects | October 14, 2014 | January 31, 2018 |
| NCT02258126 | Completed | N/A | Effect of Exercise on Hepatic Fat in Overweight Children | November 2014 | January 2018 |
| NCT05579158 | Completed | N/A | Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled Trial | February 1, 2023 | January 12, 2024 |
| NCT02267148 | Completed | Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression | October 2014 | December 2014 | |
| NCT02285205 | Completed | Phase 4 | A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD | November 2014 | November 2015 |
| NCT05578404 | Completed | Phase 2 | High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease | October 20, 2022 | April 20, 2023 |
| NCT02303314 | Completed | Phase 2/Phase 3 | Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease | November 2014 | September 2017 |
| NCT02303730 | Completed | Phase 4 | Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes | March 2015 | November 2017 |
| NCT02329405 | Completed | Phase 4 | The Effects of PXR Activation on Hepatic Fat Content | December 2014 | January 2017 |
| NCT02330549 | Completed | Phase 2 | ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD | July 17, 2015 | September 8, 2016 |
| NCT02337660 | Completed | N/A | Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia | January 2015 | January 2016 |
| NCT02366052 | Completed | Phase 2 | Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study | February 1, 2015 | May 10, 2017 |
| NCT02369536 | Completed | N/A | Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) | August 18, 2015 | September 15, 2016 |
| NCT02383485 | Completed | N/A | Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children | May 2008 | April 2014 |
| NCT02390232 | Completed | Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH | February 2015 | November 2017 | |
| NCT05560607 | Completed | Phase 1 | Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease | August 12, 2022 | February 27, 2024 |
| NCT05474560 | Completed | Phase 4 | Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients | January 1, 2022 | January 28, 2023 |
| NCT02461212 | Completed | N/A | Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth | July 1, 2015 | March 17, 2017 |
| NCT05416970 | Completed | The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution | January 1, 2018 | January 31, 2022 | |
| NCT02491905 | Completed | Phase 2 | Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients | November 2013 | May 2015 |
| NCT02496390 | Completed | Phase 1/Phase 2 | Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD | June 2016 | December 2018 |
| NCT02526732 | Completed | N/A | Hepatic Inflammation and Physical Performance in Patients With NASH | September 2015 | December 20, 2017 |
| NCT02528305 | Completed | N/A | The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/Steatohepatitis | October 2015 | June 2016 |
| NCT02535195 | Completed | Phase 2/Phase 3 | Effect of Ginger Supplement on Non-alcoholic Fatty Liver | March 2013 | August 2015 |
| NCT02568605 | Completed | N/A | Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease | May 2015 | August 2022 |
| NCT02568787 | Completed | N/A | The Effect of an RBAC Supplement (BRM4) on NAFLD | May 2016 | June 10, 2017 |
| NCT04043585 | Completed | Bariatric Surgery on NASH | July 31, 2019 | March 29, 2023 | |
| NCT04049396 | Completed | N/A | Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD) | October 1, 2018 | June 15, 2019 |
| NCT04059068 | Completed | Macrophage-mediated Inflammation in White Adipose Tissue and Non-alcoholic Fatty Liver Disease. | September 1, 2019 | September 5, 2023 | |
| NCT00389376 | Completed | Phase 1 | Phase I Trial of Silymarin for Chronic Liver Diseases | November 2006 | February 2008 |
| NCT00230087 | Completed | Phase 2 | Iron Depletion Therapy for Type 2 DM and NAFLD | September 2005 | June 2010 |
| NCT00586313 | Completed | N/A | Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.) | January 2007 | July 2008 |
| NCT00641524 | Completed | N/A | Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease | January 2009 | December 2011 |
| NCT06244550 | Completed | N/A | Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors | September 22, 2021 | June 13, 2023 |
| NCT00714129 | Completed | N/A | De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver Disease | September 2007 | October 12, 2012 |
| NCT00730873 | Completed | N/A | Fatty Liver and Obstructive Sleep Apnea | ||
| NCT00760513 | Completed | Phase 4 | Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids | November 1, 2009 | November 29, 2018 |
| NCT00794716 | Completed | Phase 2 | Pharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) | June 2008 | November 2011 |
| NCT00816465 | Completed | Phase 1 | Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) | May 2009 | August 2010 |
| NCT00819338 | Completed | Phase 2 | The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease | January 2009 | March 2010 |
| NCT00870077 | Completed | N/A | A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease | April 2009 | April 2010 |
| NCT03915002 | Completed | Integrated Approaches for Identifying Molecular Targets in Liver Disease | June 13, 2019 | April 12, 2023 | |
| NCT03936803 | Completed | N/A | Interval Training Versus Electro Acupuncture on Liver Functions in Patients With Non-alcoholic Fatty Liver Disease | May 1, 2017 | May 25, 2019 |
| NCT03938246 | Completed | Phase 2 | Study of TVB 2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) | March 22, 2019 | October 2, 2021 |
| NCT03942822 | Completed | N/A | Chia Supplementation and Non Alcoholic Fatty Liver Disease | September 1, 2016 | September 1, 2017 |
| NCT00262964 | Completed | N/A | Obesity and Nonalcoholic Fatty Liver Disease | October 2004 | December 2008 |
| NCT04130321 | Completed | N/A | Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans | October 31, 2020 | April 21, 2022 |
| NCT04117802 | Completed | N/A | Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome | September 3, 2019 | December 1, 2021 |
| NCT03995056 | Completed | N/A | Exercise Study in Subjects With NAFLD | April 19, 2019 | June 18, 2020 |
| NCT04004273 | Completed | N/A | Diabetes, Exercise and Liver Fat (DELIVER) | October 30, 2018 | July 20, 2022 |
| NCT04038853 | Completed | Phase 4 | Vitamin D in Fatty Liver Disease | December 1, 2015 | April 1, 2019 |
| NCT04042142 | Completed | N/A | Glucagon Resistance in Patients With NAFLD | October 5, 2019 | August 18, 2022 |
| NCT04098484 | Completed | N/A | Biological Adaptations of Strength Training. | April 2, 2019 | October 31, 2023 |
| NCT02599038 | Completed | Phase 1/Phase 2 | Serine Supplementation for Obese Subjects With Fatty Liver Disease | October 2015 | October 2016 |
| NCT02637973 | Completed | Phase 4 | Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes | December 2015 | August 2018 |
| NCT02642172 | Completed | N/A | Prebiotics in Patients With Non-alcoholic Liver Disease | January 2016 | March 20, 2023 |
| NCT05357352 | Completed | Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis | May 24, 2019 | April 7, 2021 | |
| NCT02649465 | Completed | Phase 4 | SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD | November 11, 2015 | June 30, 2021 |
| NCT02650830 | Completed | Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress | September 12, 2015 | July 2, 2018 | |
| NCT05357248 | Completed | N/A | Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH | April 10, 2022 | December 7, 2022 |
| NCT02679417 | Completed | N/A | The Effects of Type of Exercise in Non-alcoholic Fatty Liver Disease | August 2015 | September 2016 |
| NCT02681055 | Completed | Phase 2 | Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects | March 2016 | October 1, 2019 |
| NCT02682173 | Completed | N/A | Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver | March 2013 | July 2017 |
| NCT02696941 | Completed | Phase 1 | SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis | February 2016 | April 1, 2018 |
| NCT05325398 | Completed | N/A | Effect of Molecular Hydrogen in Patients With NAFLD | May 1, 2020 | December 18, 2020 |
| NCT05292911 | Completed | Phase 1 | Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD) | March 9, 2022 | October 31, 2022 |
| NCT02728765 | Completed | N/A | Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease | July 5, 2016 | March 30, 2019 |
| NCT02779946 | Completed | Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease | October 2015 | June 2017 | |
| NCT02784444 | Completed | Phase 2 | A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH | September 14, 2016 | June 2019 |
| NCT02787668 | Completed | N/A | A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity | May 2016 | April 2018 |
| NCT02860884 | Completed | Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease | August 2014 | October 2015 | |
| NCT05259475 | Completed | N/A | Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes (TANGO Study) | August 20, 2021 | July 31, 2022 |
| NCT02875392 | Completed | N/A | Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD) | November 2016 | March 2018 |
| NCT02884037 | Completed | Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD) | May 2012 | October 2016 | |
| NCT05231564 | Completed | N/A | Hybrid Training and Middle Age | November 1, 2019 | February 1, 2020 |
| NCT02950610 | Completed | Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver Disease | January 2016 | May 2018 | |
| NCT02951546 | Completed | N/A | Metabolic Flexibility, Gut Microbiota, Healthy Diet and Exercise in NAFLD on Genetics Base | October 2016 | February 2022 |
| NCT05200585 | Completed | N/A | Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease | May 11, 2022 | July 20, 2023 |
| NCT02974374 | Completed | Phase 1 | Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects | October 2016 | January 2017 |
| NCT02985450 | Completed | A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada | August 2016 | January 2021 | |
| NCT05194553 | Completed | Identification and Characterization of NAFLD in Turkey | February 15, 2022 | June 15, 2023 | |
| NCT03060538 | Completed | Phase 1 | A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease | March 5, 2017 | December 13, 2019 |
| NCT03060694 | Completed | Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements | September 2016 | May 2017 | |
| NCT03061721 | Completed | Phase 2 | Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis | April 6, 2017 | December 15, 2020 |
| NCT03068065 | Completed | Phase 4 | Antidiabetic Effects on Intrahepatic Fat | May 2014 | October 2015 |
| NCT03068078 | Completed | N/A | A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes | November 2016 | June 4, 2021 |
| NCT05189990 | Completed | Electrical Impedance Tomography in Fatty Liver Detection | January 1, 2022 | February 29, 2024 | |
| NCT05073588 | Completed | N/A | Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD Children | August 16, 2021 | March 30, 2023 |
| NCT03143166 | Completed | Phase 1 | Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan | May 22, 2017 | August 2, 2017 |
| NCT05006885 | Completed | Phase 1 | ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD) | September 30, 2021 | August 17, 2022 |
| NCT03166735 | Completed | Phase 2 | Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH | June 6, 2017 | June 14, 2019 |
| NCT04988633 | Completed | N/A | "CAP" Fetge Gras. Lifestyle Modification Program in Catalonia. | May 1, 2021 | July 31, 2022 |
| NCT03184376 | Completed | N/A | Histological Improvement of NASH With Prebiotic | February 28, 2012 | May 30, 2016 |
| NCT03186859 | Completed | N/A | Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease) | June 9, 2017 | August 30, 2020 |
| NCT04907721 | Completed | N/A | Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis | May 27, 2021 | October 21, 2023 |
| NCT03245606 | Completed | Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease | December 7, 2017 | July 7, 2020 | |
| NCT03250572 | Completed | Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients | June 2015 | November 2016 | |
| NCT03256526 | Completed | Phase 2 | 6-week Safety and PD Study in Adults With NAFLD | September 27, 2017 | April 27, 2018 |
| NCT04871360 | Completed | N/A | Effect of L-Citrulline Supplementation on NAFLD in Adolescents With Obesity | May 5, 2021 | January 15, 2022 |
| NCT03339245 | Completed | N/A | Effects of Dietary Fructose on Gut Microbiota and Fecal Metabolites in Obese Men and Postmenopausal Women: A Pilot Study | December 5, 2017 | October 2, 2018 |
| NCT03350165 | Completed | Phase 2 | A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) | December 27, 2017 | June 30, 2020 |
| NCT04859322 | Completed | N/A | The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover | February 8, 2021 | December 9, 2021 |
| NCT03357380 | Completed | Phase 1 | A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver | November 28, 2017 | March 20, 2020 |
| NCT03369145 | Completed | N/A | High-fat Overfeeding, Hepatokines and Appetite Regulation | December 11, 2017 | July 31, 2018 |
| NCT04857606 | Completed | Phase 1 | Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver Disease | May 24, 2021 | July 19, 2023 |
| NCT04857437 | Completed | Phase 1 | Study in Healthy Adults Evaluating PF-07202954 | May 13, 2021 | September 17, 2021 |
| NCT04800094 | Completed | N/A | Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study | March 2, 2021 | December 13, 2022 |
| NCT03439917 | Completed | N/A | Effects of Carnitine Supplementation on Liver and Muscle | April 2, 2018 | November 1, 2021 |
| NCT03444233 | Completed | Phase 4 | Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women. | August 15, 2009 | October 15, 2009 |
| NCT04782050 | Completed | N/A | Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation | September 15, 2021 | August 29, 2022 |
| NCT04688307 | Completed | N/A | Cigarette Smoking in Non-alcoholic Steatohepatitis | November 1, 2017 | December 1, 2018 |
| NCT04671186 | Completed | N/A | Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With Fibroscan | September 7, 2020 | March 1, 2023 |
| NCT04657523 | Completed | N/A | Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study | October 30, 2020 | January 18, 2023 |
| NCT03513588 | Completed | Phase 1 | 2-Week Study In People With Nonalcoholic Fatty Liver Disease | June 21, 2018 | April 4, 2019 |
| NCT03526445 | Completed | N/A | Hepatic Metabolic Changes in Response to Glucagon Infusion | May 1, 2018 | June 12, 2019 |
| NCT04642261 | Completed | Phase 4 | Effect of Empagliflozin on Liver Fat in Non-diabetic Patients | January 1, 2021 | June 30, 2023 |
| NCT03608748 | Completed | Early Detection of Advanced Fatty Liver Disease | November 1, 2018 | March 1, 2023 | |
| NCT04640324 | Completed | N/A | Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome. | January 16, 2017 | April 17, 2018 |
| NCT03614039 | Completed | N/A | Effect of Probiotic and Smectite Gel on NAFLD | September 15, 2015 | April 20, 2016 |
| NCT03625362 | Completed | N/A | Hydrogen-rich Water for Non-alchoholic Fatty Liver Disease | September 1, 2018 | December 31, 2018 |
| NCT04598685 | Completed | Early Vascular Ageing in the YOUth | February 1, 2021 | March 31, 2023 | |
| NCT04579874 | Completed | N/A | Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. | January 7, 2021 | April 15, 2022 |
| NCT04573543 | Completed | The Role of Immune Semaphorins in NAFLD | September 1, 2020 | March 1, 2022 | |
| NCT03663062 | Completed | ObeSity Related Colorectal Adenoma Risk | December 27, 2017 | June 7, 2019 | |
| NCT03681457 | Completed | Phase 1 | Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects | September 24, 2018 | September 25, 2019 |
| NCT04523584 | Completed | Ultrasound Quantification of Liver Fat | November 8, 2016 | July 22, 2021 | |
| NCT04520724 | Completed | N/A | Functional Roll for Non-alcoholic Fatty Liver Disease | November 1, 2018 | November 1, 2019 |
| NCT04422496 | Completed | Phase 1 | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects | August 10, 2020 | February 23, 2021 |
| NCT03791203 | Completed | N/A | Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver Disease | August 1, 2015 | October 1, 2017 |
| NCT03796975 | Completed | Phase 4 | Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease | June 28, 2018 | November 20, 2019 |
| NCT04411862 | Completed | Phase 3 | Efficacy of Phosphatidylcholine in NAFLD | January 2, 2016 | July 1, 2019 |
| NCT04384159 | Completed | Combination Diagnostic Strategies in NAFLD | November 30, 2011 | July 31, 2019 | |
| NCT04342390 | Completed | N/A | Effects of High-Intensity Interval Training Exercise in Adolescents With Hepatosteatosis | April 2, 2021 | November 1, 2022 |
| NCT04341246 | Completed | Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH) | January 28, 2021 | June 12, 2023 | |
| NCT03826381 | Completed | NAFLD Among Patients With Type 2 Diabetes and CKD | May 6, 2019 | June 23, 2021 | |
| NCT03836937 | Completed | N/A | Role of Obeticholic Acid in the Patients of NAFLD With Raised ALT | March 5, 2019 | December 31, 2021 |
| NCT03839082 | Completed | N/A | Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver Disease | March 20, 2019 | February 26, 2021 |
| NCT04336800 | Completed | Multi-Parametric MRI Assessment of the Liver in Diabetic Volunteers (Partners Registry) | April 1, 2020 | January 1, 2022 | |
| NCT04336618 | Completed | Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population | August 3, 2020 | September 27, 2022 | |
| NCT03864783 | Completed | N/A | The Effect of Curcumin on Liver Fat Content in Obese Subjects | March 5, 2019 | December 16, 2020 |
| NCT04216589 | Completed | Phase 2 | Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study) | February 19, 2021 | September 15, 2023 |
| NCT04198805 | Completed | Phase 2 | Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) | January 3, 2020 | September 1, 2022 |
| NCT00230113 | Completed | Phase 2 | Effect of Omega-3 PUFA Supplementation in NAFLD Patients | September 2005 | June 2010 |
| NCT04197479 | Completed | Phase 3 | A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients | December 16, 2019 | January 6, 2023 |
| NCT04142749 | Completed | Phase 3 | Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis | November 15, 2019 | September 26, 2022 |
| NCT03910361 | Completed | Phase 4 | Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases | April 12, 2019 | July 2, 2020 |
| NCT02498990 | Enrolling by invitation | N/A | Low Calorie Diet and Diabetes | August 2015 | August 2025 |
| NCT05676177 | Enrolling by invitation | N/A | CT Liver Fat Fraction Quantification | January 29, 2023 | December 31, 2025 |
| NCT05551559 | Enrolling by invitation | N/A | The Effect of Bariatric Surgery on Hepatic Metabolism in Non-Alcoholic Fatty Liver Disease | September 12, 2022 | August 2027 |
| NCT05956379 | Enrolling by invitation | N/A | Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention. | August 1, 2023 | July 31, 2027 |
| NCT05291104 | Enrolling by invitation | N/A | Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression | April 1, 2022 | July 31, 2024 |
| NCT06026293 | Enrolling by invitation | Pharmacoeconomic Evaluation of the Cost/Effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease | July 20, 2023 | October 30, 2023 | |
| NCT06011356 | Enrolling by invitation | Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study | August 30, 2023 | August 30, 2026 | |
| NCT06097039 | Enrolling by invitation | Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease | August 1, 2023 | January 20, 2024 | |
| NCT05563259 | Enrolling by invitation | Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver Disease | May 1, 2020 | September 2025 | |
| NCT03701828 | Enrolling by invitation | N/A | Liver Health and Metabolic Function in People With Obesity | February 1, 2019 | November 1, 2024 |
| NCT04004403 | Enrolling by invitation | N/A | Alternate Day Fasting, Exercise, and NAFLD | September 1, 2019 | May 1, 2024 |
| NCT06152991 | Enrolling by invitation | Phase 3 | Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy | September 25, 2023 | February 26, 2027 |
| NCT06465186 | Not yet recruiting | Phase 2 | A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017) | July 18, 2024 | May 15, 2026 |
| NCT03867487 | Not yet recruiting | Phase 2 | SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease | May 1, 2024 | December 31, 2029 |
| NCT03970031 | Not yet recruiting | Phase 3 | A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH | June 2022 | September 2024 |
| NCT04540731 | Not yet recruiting | Multicenter Registry of Nonalcoholic Fatty Liver Disease | October 2020 | October 2025 | |
| NCT04690972 | Not yet recruiting | "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". | December 20, 2020 | December 4, 2028 | |
| NCT05203367 | Not yet recruiting | Phase 1 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects | November 25, 2022 | March 30, 2023 |
| NCT05447351 | Not yet recruiting | Beneficial Effects of Dietary and Lifestyle Change in Overweight and Obese Subjects | January 2023 | June 2025 | |
| NCT05526274 | Not yet recruiting | Clinical Epidemiology of NAFLD in Children and Adolescents | October 2022 | December 2023 | |
| NCT05623150 | Not yet recruiting | CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome | December 1, 2022 | March 2032 | |
| NCT05686174 | Not yet recruiting | Phase 1 | Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD | February 1, 2023 | December 31, 2024 |
| NCT05894993 | Not yet recruiting | Transient Elastograghy to Detect Non Alcoholic Fatty Liver Disease in Renal Transplantation Recipients. | November 1, 2023 | January 30, 2025 | |
| NCT05907408 | Not yet recruiting | Omics Techniques in Fatty Liver Disease | July 1, 2023 | December 31, 2023 | |
| NCT05942963 | Not yet recruiting | Phase 4 | Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD | October 2023 | April 2024 |
| NCT05987748 | Not yet recruiting | N/A | The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD? | September 1, 2023 | September 1, 2024 |
| NCT06126354 | Not yet recruiting | Phase 1 | Dexamethasone/Pancreatic Clamp P&F | July 1, 2024 | March 31, 2026 |
| NCT06138821 | Not yet recruiting | Phase 4 | ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial | July 2024 | December 2025 |
| NCT06167902 | Not yet recruiting | N/A | The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial | December 25, 2023 | December 25, 2025 |
| NCT06206616 | Not yet recruiting | Liver Steatosis in Pediatric CD Patients | June 1, 2024 | September 30, 2026 | |
| NCT06211868 | Not yet recruiting | Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study | February 1, 2024 | February 1, 2030 | |
| NCT06218342 | Not yet recruiting | Phase 4 | Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease | February 15, 2024 | December 31, 2025 |
| NCT06240039 | Not yet recruiting | N/A | Direct Versus Indirect Effect of Amino Acids on Hepatokines | February 2024 | December 2026 |
| NCT06256289 | Not yet recruiting | Phase 4 | Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome | March 31, 2024 | April 30, 2025 |
| NCT06266559 | Not yet recruiting | N/A | Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver Disease | February 15, 2024 | December 31, 2025 |
| NCT06355310 | Not yet recruiting | Phase 2 | Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease | May 20, 2024 | December 31, 2028 |
| NCT06373523 | Not yet recruiting | Early Phase 1 | MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin | May 1, 2024 | July 30, 2025 |
| NCT06374875 | Not yet recruiting | N/A | Fibrosis Lessens After Metabolic Surgery | May 1, 2024 | December 31, 2029 |
| NCT06450769 | Not yet recruiting | N/A | Aronia and Non-alcoholic Fatty Liver Disease | June 15, 2024 | June 15, 2026 |
| NCT03811236 | Recruiting | N/A | Cold-induced Brown Fat Activation and Hepatic Steatosis | January 21, 2019 | December 2026 |
| NCT04365855 | Recruiting | N/A | The Olmsted NAFLD Epidemiology Study (TONES) | September 29, 2020 | June 2028 |
| NCT04475276 | Recruiting | Phase 4 | Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases | February 23, 2021 | December 31, 2023 |
| NCT04501042 | Recruiting | Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric Surgery | May 16, 2019 | September 1, 2024 | |
| NCT03749070 | Recruiting | N/A | Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The SILIVER Trial | February 15, 2019 | August 31, 2022 |
| NCT06225713 | Recruiting | N/A | Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD) | February 2, 2024 | December 31, 2024 |
| NCT03535142 | Recruiting | N/A | Prognostic Significance of Fatty Liver Disease in Bariatric Patients | August 15, 2018 | April 1, 2038 |
| NCT04647409 | Recruiting | N/A | Screening for NAFLD in Flanders | October 26, 2020 | December 31, 2024 |
| NCT04666402 | Recruiting | Integrated Diagnostics for Early Diagnosis of Liver Disease | October 21, 2020 | April 1, 2025 | |
| NCT06133101 | Recruiting | Phase 2 | Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD) | January 15, 2024 | June 2026 |
| NCT04720560 | Recruiting | Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease | December 1, 2023 | September 1, 2024 | |
| NCT04807868 | Recruiting | AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL) | April 22, 2021 | March 2026 | |
| NCT04899102 | Recruiting | N/A | Intermittent Fasting for NAFLD in Adults | February 1, 2022 | July 31, 2025 |
| NCT03190538 | Recruiting | Nonalcoholic Steatohepatitis in Chinese Children | May 1, 2017 | May 31, 2028 | |
| NCT04918732 | Recruiting | N/A | NAFLD Primary Care | May 5, 2021 | December 31, 2024 |
| NCT04951219 | Recruiting | Phase 3 | A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) | July 9, 2021 | April 2026 |
| NCT04969744 | Recruiting | N/A | Impact of Cold Exposure on Metabolic Regulation in Children With Non Alcoholic Fatty Liver Disease (NAFLD) | October 23, 2021 | December 2024 |
| NCT04999124 | Recruiting | N/A | Characteristics of NAFLD Among Type 2 Diabetes Patients | January 1, 2020 | May 30, 2024 |
| NCT05046483 | Recruiting | Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI | December 30, 2018 | December 30, 2029 | |
| NCT05067621 | Recruiting | Phase 2 | Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease | July 17, 2023 | January 2027 |
| NCT05180760 | Recruiting | N/A | Smartphone App for Non-alcoholic Fatty Liver Disease | July 1, 2023 | December 31, 2026 |
| NCT03073343 | Recruiting | N/A | A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine | November 12, 2013 | December 30, 2025 |
| NCT05200156 | Recruiting | N/A | Impact Of Choline in Patients With NAFLD | February 1, 2022 | February 1, 2024 |
| NCT06354088 | Recruiting | Phase 1 | Human Models of Selective Insulin Resistance: Alpelisib, Part I | April 24, 2024 | December 2026 |
| NCT05216796 | Recruiting | N/A | Healthy Liver - Healthy Brain | May 18, 2022 | September 2024 |
| NCT05256979 | Recruiting | Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation | July 2, 2022 | July 2024 | |
| NCT05268042 | Recruiting | N/A | Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents | May 1, 2022 | March 31, 2026 |
| NCT05275608 | Recruiting | N/A | Effects of VLCKD in Metabolic Syndrome | November 7, 2022 | December 2024 |
| NCT05292352 | Recruiting | N/A | Prevention of NAFLD in Hispanic Children | April 6, 2022 | June 2026 |
| NCT05305287 | Recruiting | Phase 4 | Quantifying Hepatic Mitochondrial Fluxes in Humans | November 1, 2022 | March 31, 2027 |
| NCT05332613 | Recruiting | N/A | Diet and Meal Timing in Patients With Non-Alcoholic Fatty Liver Disease: A Pilot Study | April 27, 2022 | December 31, 2025 |
| NCT02663388 | Recruiting | Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection) | January 2016 | January 2026 | |
| NCT05395481 | Recruiting | Phase 1 | A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Nonalcoholic Fatty Liver Disease | June 8, 2022 | November 5, 2024 |
| NCT05402449 | Recruiting | N/A | To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation | July 14, 2022 | May 31, 2024 |
| NCT05419765 | Recruiting | Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease | March 1, 2022 | December 31, 2024 | |
| NCT06140953 | Recruiting | Phase 2 | Benefits of Trimetazidine in MAFLD Pateints | December 10, 2023 | September 2025 |
| NCT05462353 | Recruiting | Phase 2 | Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH | September 30, 2022 | June 10, 2025 |
| NCT05463796 | Recruiting | InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer | April 25, 2023 | March 25, 2032 | |
| NCT05464784 | Recruiting | Phase 2 | MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia | August 22, 2022 | December 31, 2024 |
| NCT05480696 | Recruiting | Phase 1 | Soluble Fibre Supplementation in NAFLD | September 9, 2022 | March 2027 |
| NCT05486429 | Recruiting | Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by Ultrasound | July 20, 2022 | January 20, 2023 | |
| NCT05499585 | Recruiting | N/A | Treating Pediatric NAFLD With Nutrition | September 12, 2022 | October 2024 |
| NCT05520697 | Recruiting | N/A | Exercise and Cerebral Hemodynamics in MAFLD. | December 1, 2020 | December 31, 2024 |
| NCT06144593 | Recruiting | N/A | The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes | January 3, 2024 | September 1, 2025 |
| NCT05528471 | Recruiting | N/A | Fructose and Liver Diseases in Youth: Help Them FLY | April 30, 2015 | December 30, 2024 |
| NCT05546086 | Recruiting | BeijngFH Health Cohort Study | April 18, 2022 | April 18, 2032 | |
| NCT05560997 | Recruiting | Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease | January 5, 2016 | June 1, 2024 | |
| NCT02298439 | Recruiting | Fatty Liver Patient Registry | October 2013 | June 2026 | |
| NCT05613192 | Recruiting | Phase 3 | Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease Patients | October 31, 2022 | March 5, 2023 |
| NCT05618626 | Recruiting | N/A | Prevention of NAFLD and CVD Through Lifestyle Intervention | September 27, 2021 | April 30, 2025 |
| NCT05654129 | Recruiting | N/A | Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver Disease | December 5, 2022 | December 5, 2023 |
| NCT05696808 | Recruiting | N/A | Effect of Indian Hepatoprotective Diet in Reversibility of NAFLD | January 16, 2023 | January 13, 2024 |
| NCT05712603 | Recruiting | The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study | October 1, 2022 | March 30, 2026 | |
| NCT05724134 | Recruiting | Phase 1 | Pancreatic Clamp in NAFLD | August 29, 2023 | January 2025 |
| NCT05728697 | Recruiting | Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease | June 1, 2021 | May 31, 2025 | |
| NCT05729282 | Recruiting | Phase 1 | Glycemic Effect of Diazoxide in NAFLD | August 1, 2023 | January 2025 |
| NCT05741957 | Recruiting | N/A | Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease | March 2, 2023 | December 31, 2026 |
| NCT05751720 | Recruiting | Phase 1/Phase 2 | Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue | October 1, 2023 | February 2025 |
| NCT05754385 | Recruiting | N/A | Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease | May 1, 2023 | October 31, 2025 |
| NCT05766449 | Recruiting | Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD | June 1, 2022 | May 1, 2027 | |
| NCT05779644 | Recruiting | N/A | Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus | February 23, 2023 | February 23, 2025 |
| NCT05786963 | Recruiting | Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis | December 29, 2022 | April 2024 | |
| NCT05792488 | Recruiting | N/A | Lifestyle Guidance Methods in NAFLD | October 24, 2022 | November 1, 2025 |
| NCT05802199 | Recruiting | Quantitative Detection Efficiency of UDFF for Nonalcoholic Fatty Liver Disease | January 1, 2023 | December 31, 2023 | |
| NCT01988441 | Recruiting | The Influence of Autophagy on Fatty Liver | September 2013 | August 2025 | |
| NCT05821010 | Recruiting | Phase 2 | Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis | March 17, 2023 | August 20, 2025 |
| NCT05858138 | Recruiting | N/A | To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver Disease | May 3, 2022 | December 31, 2023 |
| NCT05866744 | Recruiting | N/A | Effects of Time-restricted Hypocaloric Diet in Patients With NAFLD | May 8, 2023 | July 30, 2024 |
| NCT05870969 | Recruiting | Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) | March 1, 2023 | March 2028 | |
| NCT05877547 | Recruiting | Phase 2 | A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) | June 23, 2023 | December 5, 2025 |
| NCT05890365 | Recruiting | Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals | December 14, 2023 | December 2024 | |
| NCT06176079 | Recruiting | Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease | July 22, 2020 | February 28, 2025 | |
| NCT00575133 | Recruiting | Prospective Cohort Study in Patients With NAFLD | December 2007 | November 2027 | |
| NCT05941910 | Recruiting | Phase 2 | The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function | April 1, 2023 | December 31, 2023 |
| NCT06392828 | Recruiting | EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular Diseases | April 15, 2024 | December 31, 2025 | |
| NCT05968378 | Recruiting | N/A | Diet, Immunometabolism and Non-alcoholic Fatty Liver Disease | June 1, 2023 | July 2024 |
| NCT05970640 | Recruiting | Phase 1 | A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease | August 2, 2023 | January 4, 2025 |
| NCT05979779 | Recruiting | Phase 2 | Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis | September 5, 2023 | April 2025 |
| NCT06005012 | Recruiting | Phase 2 | Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM | July 25, 2023 | June 2025 |
| NCT06007651 | Recruiting | Phase 1 | A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD) | August 10, 2023 | April 15, 2025 |
| NCT06015620 | Recruiting | Comorbidities Resolution After MGB Surgery and Change in Body Composition | September 1, 2023 | September 30, 2026 | |
| NCT06032650 | Recruiting | N/A | Calisthenics Versus High Intensity Interval Training in NAFL | October 15, 2023 | November 2024 |
| NCT06053177 | Recruiting | Multi-morbidity Screening in People With Type 2 Diabetes and Pre Diabetes | January 25, 2023 | February 3, 2025 | |
| NCT06061042 | Recruiting | N/A | Effect of Timed-Restricted Eating on Metabolic Health | October 2023 | December 2027 |
| NCT06064240 | Recruiting | Liver Fat Content and Bariatric Surgery | May 1, 2022 | October 1, 2025 | |
| NCT06095479 | Recruiting | N/A | Ultrasound Liver Fat Quantification on Pediatric Patients | July 6, 2021 | June 30, 2024 |
| NCT06101758 | Recruiting | N/A | Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study | October 20, 2023 | July 2025 |
| NCT06104319 | Recruiting | Phase 2 | Dose Exploration Study of GSK4532990 in Participants With NASH or Suspected NASH | January 22, 2024 | June 27, 2025 |
| NCT06113003 | Recruiting | Phase 1/Phase 2 | The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease | April 18, 2024 | July 2025 |
| NCT03985020 | Recruiting | N/A | Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis | July 26, 2019 | December 31, 2023 |
| NCT04141592 | Recruiting | Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease | February 19, 2019 | December 29, 2023 | |
| NCT03884075 | Recruiting | Phase 2 | Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) | July 24, 2019 | August 1, 2024 |
| NCT04190849 | Recruiting | European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD) | November 14, 2017 | November 2047 | |
| NCT03875625 | Recruiting | N/A | Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention | April 1, 2019 | June 30, 2025 |
| NCT04302051 | Recruiting | Assessment of Fatty Liver With Thermo-acoustic Device | November 2, 2023 | December 30, 2025 | |
| NCT04340817 | Recruiting | Fatty Liver Disease in Nordic Countries | September 1, 2017 | November 1, 2026 | |
| NCT03819283 | Recruiting | N/A | NASH and Coronary Disease | April 19, 2019 | July 19, 2024 |
| NCT05827432 | Suspended | N/A | FCI Effectiveness in NAFLD Stratification | March 2024 | March 2025 |
| NCT00694746 | Terminated | Phase 1 | Study of Fish Oil to Reduce ALT Levels in Adolescents | June 2008 | March 2014 |
| NCT01167088 | Terminated | Phase 2 | A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD) | November 2010 | July 2011 |
| NCT03866421 | Terminated | NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation | May 29, 2019 | March 31, 2022 | |
| NCT01629095 | Terminated | Genetic Studies of Non-Alcoholic Fatty Liver Disease | April 23, 2013 | January 9, 2017 | |
| NCT04315350 | Terminated | N/A | The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance | December 1, 2019 | June 11, 2021 |
| NCT04048876 | Terminated | Phase 2 | Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis | August 14, 2019 | September 28, 2021 |
| NCT03281083 | Terminated | Phase 2 | Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD) | March 28, 2014 | July 28, 2016 |
| NCT03059446 | Terminated | Phase 2 | Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis | February 14, 2017 | January 5, 2021 |
| NCT03436420 | Terminated | Phase 2 | Gemcabene for the Treatment of Pediatric NAFLD | March 29, 2018 | August 27, 2019 |
| NCT00677521 | Terminated | Phase 2 | A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD) | January 2007 | August 2008 |
| NCT04147195 | Terminated | Phase 2 | Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) | June 4, 2020 | January 6, 2022 |
| NCT03142867 | Terminated | The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Adults | August 25, 2015 | June 27, 2019 | |
| NCT04440540 | Terminated | N/A | Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study | July 2, 2020 | June 30, 2023 |
| NCT02086708 | Terminated | N/A | Ultrasound Method to Measure Fibrosis of the Liver in Children | June 2010 | March 2015 |
| NCT02930161 | Terminated | Phase 2 | Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome | May 30, 2016 | October 10, 2018 |
| NCT03511365 | Terminated | Phase 1/Phase 2 | Effects of Probiotic on Inflammation and Microbiota in Patients With NASH | May 15, 2018 | October 11, 2019 |
| NCT04237116 | Terminated | Phase 3 | A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD) | February 19, 2020 | July 23, 2021 |
| NCT02400099 | Unknown status | N/A | Protein-rich Diet and NAFLD in Bariatric Surgery | June 2015 | |
| NCT02391168 | Unknown status | Fatty Liver Disease Collaborative Research in China | July 2015 | December 2020 | |
| NCT03492879 | Unknown status | N/A | Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity | May 15, 2018 | May 30, 2019 |
| NCT03487068 | Unknown status | N/A | Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver Disease | April 30, 2018 | May 30, 2019 |
| NCT03864744 | Unknown status | Hepatic Histology and Metabolism Following Total Pancreatectomy and Pancreaticoduodenectomy | January 30, 2019 | August 30, 2022 | |
| NCT02285218 | Unknown status | Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD | April 2014 | March 2019 | |
| NCT03467282 | Unknown status | N/A | Probiotics in NASH Patients - PROBILIVER TRIAL | November 29, 2017 | December 20, 2021 |
| NCT04783116 | Unknown status | N/A | Plant Stanols and Liver Inflammation in Overweight and Obese Children | March 15, 2021 | December 31, 2022 |
| NCT04785937 | Unknown status | N/A | Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients | January 1, 2019 | June 1, 2022 |
| NCT04841915 | Unknown status | N/A | A Randomized Controlled Trial of Effects of DAIry PROtein Products on Liver Disease Severity and Metabolism in Patients With Non-Alcoholic Fatty Liver Disease. | March 15, 2021 | July 2023 |
| NCT04850547 | Unknown status | Effect of Fatty Liver Disease on Bone Density | May 2021 | May 2022 | |
| NCT04364360 | Unknown status | N/A | Sulforaphane Supplementation Study | January 1, 2020 | August 2023 |
| NCT03373643 | Unknown status | N/A | Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease | December 14, 2017 | March 14, 2020 |
| NCT03354247 | Unknown status | N/A | Lifestyle Intervention in Fatty Liver (NAFLD) | July 1, 2017 | December 31, 2020 |
| NCT04882644 | Unknown status | N/A | Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease (NAFLD) | May 14, 2021 | October 2022 |
| NCT02174367 | Unknown status | An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis | November 2012 | July 2021 | |
| NCT01619215 | Unknown status | The Effects of Bariatric Surgeries on Non-Alcoholic Fatty Liver Disease | June 2012 | July 2018 | |
| NCT04230655 | Unknown status | N/A | Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric Balloon | December 10, 2019 | December 2022 |
| NCT04938843 | Unknown status | N/A | Effect of F. Prausnitzii on Glycemic Control | August 16, 2021 | December 31, 2023 |
| NCT02124577 | Unknown status | Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLD | May 2014 | May 2021 | |
| NCT03183193 | Unknown status | N/A | Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO) | June 2016 | December 2019 |
| NCT04989062 | Unknown status | Predicting Obesity Consequences Using Body Measure and Urine Metabolomics | August 1, 2020 | July 31, 2022 | |
| NCT04074889 | Unknown status | N/A | The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty Liver | August 30, 2019 | December 2020 |
| NCT03156881 | Unknown status | N/A | Global Osteopathic Treatment for Patients With NAFLD | July 2017 | May 2018 |
| NCT05042245 | Unknown status | Phase 4 | The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules | April 26, 2019 | June 2022 |
| NCT05054712 | Unknown status | Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes Mellitus | September 1, 2021 | January 1, 2024 | |
| NCT05063968 | Unknown status | Phase 1 | A Clinical Trial of XZP-6019 Tablets in Healthy Subjects | November 30, 2021 | September 30, 2022 |
| NCT03128918 | Unknown status | Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients | July 2015 | September 2017 | |
| NCT05106049 | Unknown status | Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease. | December 2021 | January 2023 | |
| NCT05120557 | Unknown status | N/A | Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH | September 2022 | September 2023 |
| NCT01472120 | Unknown status | Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD) | December 2011 | January 2013 | |
| NCT01363791 | Unknown status | Meta-analyses of Fructose and Cardiometabolic Risk | May 2009 | March 2016 | |
| NCT04101162 | Unknown status | N/A | NAFLD Study: US vs Liver Biopsy | September 15, 2019 | December 15, 2020 |
| NCT02947568 | Unknown status | Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease | March 2016 | December 31, 2020 | |
| NCT04104282 | Unknown status | the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. | December 1, 2016 | December 27, 2020 | |
| NCT05217745 | Unknown status | N/A | MLCT Oil for Fatty Liver - PASS Trial | August 5, 2021 | March 31, 2023 |
| NCT05245890 | Unknown status | Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD Individuals | March 1, 2022 | March 1, 2024 | |
| NCT03426111 | Unknown status | N/A | Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO). | April 18, 2018 | December 2020 |
| NCT03848390 | Unknown status | N/A | Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD). | April 1, 2019 | April 30, 2020 |
| NCT03803540 | Unknown status | Phase 1 | Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic Steatohepatitis | May 1, 2022 | April 1, 2023 |
| NCT04400864 | Unknown status | N/A | Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver Disease | December 30, 2019 | May 1, 2021 |
| NCT03801577 | Unknown status | N/A | Hepaxa Management of Non-alcoholic Fatty Liver Disease | February 2019 | December 2019 |
| NCT03787108 | Unknown status | Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or Obesity | March 31, 2019 | December 2019 | |
| NCT04435054 | Unknown status | N/A | Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology. | October 28, 2020 | October 2023 |
| NCT03842748 | Unknown status | Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis | January 1, 2018 | December 30, 2021 | |
| NCT00941642 | Unknown status | Phase 4 | Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease | September 2009 | September 2012 |
| NCT03743272 | Unknown status | Repeatability and Reproducibility of Multiparametric MRI | June 3, 2017 | November 1, 2022 | |
| NCT04555434 | Unknown status | N/A | Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH | October 1, 2019 | September 11, 2020 |
| NCT03648086 | Unknown status | N/A | Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease | November 14, 2017 | November 2020 |
| NCT04574557 | Unknown status | Micro RNA Levels in NAFLD | October 15, 2020 | November 15, 2022 | |
| NCT04575506 | Unknown status | N/A | Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty Liver | November 16, 2020 | December 30, 2021 |
| NCT03635541 | Unknown status | Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease | August 23, 2018 | December 2021 | |
| NCT04594954 | Unknown status | N/A | Effects of Fecal Microbiota Transplantation on Weight in Obese Patients With Non-alcoholic Fatty Liver Disease | October 15, 2020 | September 30, 2021 |
| NCT03627819 | Unknown status | N/A | Plant Sterols and Plant Stanols and Liver Inflammation | May 4, 2018 | December 2019 |
| NCT03613480 | Unknown status | N/A | Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD) | September 1, 2018 | December 1, 2022 |
| NCT01083992 | Unknown status | N/A | Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) | April 2012 | June 2013 |
| NCT02488941 | Unknown status | Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease | June 2015 | May 2018 | |
| NCT02075164 | Unknown status | N/A | Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLD | May 2013 | December 2021 |
| NCT01791452 | Unknown status | Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study | |||
| NCT01680003 | Unknown status | Phase 2 | Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease | September 2012 | December 2013 |
| NCT02420054 | Unknown status | N/A | Short Term Intermittent Fasting and Insulin Resistance | April 2015 | June 2021 |
| NCT04182646 | Unknown status | N/A | Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver Disease | January 8, 2020 | December 31, 2020 |
| NCT02077283 | Unknown status | Urinary Metabonomics of Two Major Patterns of NAFLD | January 2014 | November 2017 | |
| NCT02764047 | Unknown status | N/A | Probiotics in the Treatment of NAFLD | January 2015 | January 2018 |
| NCT03972631 | Unknown status | N/A | Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese Adults | July 2019 | December 2021 |
| NCT02716870 | Unknown status | Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors | June 2015 | December 2020 | |
| NCT05301231 | Unknown status | Omics-based Predictors of NAFLD/Potential NASH | August 1, 2022 | April 30, 2024 | |
| NCT04355910 | Unknown status | N/A | Intermittent Fasting in Nonalcoholic Fatty Liver Disease | January 1, 2018 | August 31, 2020 |
| NCT02702479 | Unknown status | Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk | June 2014 | June 2016 | |
| NCT01306396 | Unknown status | N/A | Effect of Fructose Reduction on Non-alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome in Overweight Children | April 2009 | December 2012 |
| NCT02644239 | Unknown status | N/A | Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy | June 2012 | July 2020 |
| NCT02863393 | Withdrawn | N/A | Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver Disease | August 29, 2017 | March 2018 |
| NCT00816296 | Withdrawn | Evaluation of Intestinal Microbiome in Obese Kids | October 2008 | October 2012 | |
| NCT02973295 | Withdrawn | Phase 4 | Silymarin in NAFLD | September 20, 2019 | June 30, 2021 |
| NCT02263677 | Withdrawn | Phase 4 | Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI | March 2014 | January 2016 |
| NCT01849081 | Withdrawn | N/A | Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty Liver | March 2019 | March 2019 |
| NCT05130346 | Withdrawn | N/A | Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease | February 2023 | December 2023 |
| NCT03864835 | Withdrawn | N/A | NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction Reversal | November 1, 2019 | December 31, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D065626